Close Menu

This article has been updated from a previous version to include financial details about Qiagen's acquisition of Formulatrix's digital PCR assets.

NEW YORK (GenomeWeb) – Qiagen yesterday announced several new product initiatives and acquisitions to coincide with the first day of the JP Morgan Healthcare Conference, as it continues to stake its claim as one of the most diversified life science research tools and molecular diagnostics companies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.